Deutsche Bank AG Takes $3.39 Million Position in Integer Holdings Corporation $ITGR

Deutsche Bank AG bought a new stake in shares of Integer Holdings Corporation (NYSE:ITGR) during the second quarter, HoldingsChannel.com reports. The institutional investor bought 36,253 shares of the medical equipment provider’s stock, valued at approximately $3,388,000.

Other hedge funds also recently bought and sold shares of the company. Heartland Advisors Inc. grew its position in shares of Integer by 506.8% during the fourth quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after purchasing an additional 202,715 shares in the last quarter. WINTON GROUP Ltd purchased a new stake in shares of Integer in the fourth quarter worth about $4,836,000. Jennison Associates LLC purchased a new stake in shares of Integer in the fourth quarter worth about $1,036,000. Kestrel Investment Management Corp bought a new position in Integer during the fourth quarter valued at approximately $5,933,000. Finally, William Blair Investment Management LLC boosted its stake in Integer by 70.1% during the fourth quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock valued at $36,735,000 after buying an additional 192,956 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on ITGR. Freedom Capital downgraded Integer from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Wells Fargo & Company increased their target price on Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 4th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Piper Sandler cut shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target on the stock. in a research report on Monday, August 3rd. Finally, Citigroup upped their price target on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $109.86.

Integer Price Performance

NYSE:ITGR opened at $125.32 on Thursday. The firm has a market capitalization of $4.26 billion, a price-to-earnings ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $126.14. The business has a 50 day simple moving average of $106.20 and a 200-day simple moving average of $93.99. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. During the same quarter in the previous year, the company posted $1.55 EPS. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. Equities analysts forecast that Integer Holdings Corporation will post 6.09 EPS for the current year.

Key Stories Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
• Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
• Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.